All requests are reviewed by qualified healthcare professionals.
- Email: support@novametabolic.com
- Phone: 555
-
English
English
Metabolic Health
Zepbound® (tirzepatide) is a prescription once-weekly injectable medication used for chronic weight management in adults with obesity or overweight with weight-related medical conditions. It is designed to support significant, clinically proven weight loss when used alongside a reduced-calorie diet and increased physical activity. Zepbound is a first-in-class dual GIP and GLP-1 receptor agonist, helping regulate appetite, food intake, and metabolism through two complementary hormone pathways.
Zepbound® (tirzepatide) is a prescription once-weekly injectable medication used for chronic weight management in adults with obesity or overweight with weight-related health conditions. It is designed to support meaningful, sustained weight loss when combined with diet and physical activity.
Zepbound activates both GIP and GLP-1 receptors, which helps:
Zepbound is a prescription medication intended for chronic weight management and should be used under medical supervision. It is not a short-term or cosmetic weight loss solution.
Common side effects may include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort, especially during dose escalation.
| Starting Dose | 2.5mg once weekly (weeks 1-4) |
|---|---|
| Dose Step 2 | 5mg once weekly (weeks 5-8) |
| Dose Step 3 | 7.5mg once weekly (weeks 9-12) |
| Dose Step 4 | 10mg once weekly (weeks 13-16) |
| Maximum Dose | 15mg once weekly |
| Administration | Subcutaneous injection — abdomen, thigh, or upper arm |
| Supply | 4-week supply per order |
| Form | Single-dose auto-injector pen |
| Active Ingredient | Tirzepatide |
| FDA Approval | Approved for chronic weight management in adults |
| Mechanism | Dual GIP and GLP-1 receptor agonist |
| Rx Required | Yes — provider review included |
 Injection&media=https://novametabolic.com/assets/images/product/69dfa7db613301776265179.png){kind=link}